- Previous Close
4.6600 - Open
4.6100 - Bid --
- Ask --
- Day's Range
4.3300 - 4.6128 - 52 Week Range
2.8400 - 9.3500 - Volume
627,181 - Avg. Volume
943,269 - Market Cap (intraday)
244.097M - Beta (5Y Monthly) 2.70
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4700 - Earnings Date Feb 6, 2025 - Feb 10, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
www.auroramj.com1,073
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ACB
View MorePerformance Overview: ACB
Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACB
View MoreValuation Measures
Market Cap
244.10M
Enterprise Value
255.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.17
Price/Book (mrq)
0.64
Enterprise Value/Revenue
1.23
Enterprise Value/EBITDA
97.22
Financial Highlights
Profitability and Income Statement
Profit Margin
-14.71%
Return on Assets (ttm)
-1.24%
Return on Equity (ttm)
-5.79%
Revenue (ttm)
296.99M
Net Income Avi to Common (ttm)
-29.77M
Diluted EPS (ttm)
-0.4700
Balance Sheet and Cash Flow
Total Cash (mrq)
84.92M
Total Debt/Equity (mrq)
17.32%
Levered Free Cash Flow (ttm)
-84.08M